ym 12617 has been researched along with wb 4101 in 1 studies
Studies (ym 12617) | Trials (ym 12617) | Recent Studies (post-2010) (ym 12617) | Studies (wb 4101) | Trials (wb 4101) | Recent Studies (post-2010) (wb 4101) |
---|---|---|---|---|---|
32 | 2 | 6 | 477 | 1 | 34 |
Protein | Taxonomy | ym 12617 (IC50) | wb 4101 (IC50) |
---|---|---|---|
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Honda, K; Miyata-Osawa, A; Shiono, K; Takenaka, T; Terai, M | 1 |
1 other study(ies) available for ym 12617 and wb 4101
Article | Year |
---|---|
Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Brain; Brimonidine Tartrate; Clonidine; Dioxanes; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Phenylephrine; Pulmonary Artery; Quinoxalines; Rabbits; Rats; Receptors, Adrenergic, alpha; Sulfonamides; Tritium; Vas Deferens | 1985 |